| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Amgen Institute and Ontario Cancer Institute, Departments of Medical Biophysics and Immunology, University of Toronto, Toronto, Ontario, Canada;
Skirball Institute of Biomolecular Medicine, Department of Pathology, New York University School of Medicine, New York, NY 10016; and
Howard Hughes Medical Institute, Center for Cancer Research, and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
Multiple sclerosis (MS) is a severe central nervous system disease. Experimental autoimmune encephalomyelitis (EAE) mimics MS in mice. We report that spontaneous development of EAE in RAG-1-deficient mice transgenic for a myelin basic protein (MBP)-specific TCR (TgMBP+/RAG-1-/-) requires expression of the T cell costimulatory molecule CD28. Surprisingly, T cells from CD28-/-TgMBP+/RAG-1-/- mice proliferate and produce IL-2 in response to MBP1–17 peptide in vitro, excluding clonal anergy as the mechanism of CD28-regulated pathogenesis. Proliferation of autoaggressive T cells was dependent on the concentration of the MBP peptide, as was the development of MBP-induced EAE in CD28-deficient PL/J mice. These results provide the first genetic evidence that CD28 costimulation is crucial for MBP-specific T cell activation in vivo and the initiation of spontaneous EAE.
This article has been cited by other articles:
|
|
 |
|
  C. M. Krawczyk, R. G. Jones, A. Atfield, K. Bachmaier, S. Arya, B. Odermatt, P. S. Ohashi, and J. M. Penninger Differential Control of CD28-Regulated In Vivo Immunity by the E3 Ligase Cbl-b J. Immunol., February 1, 2005; 174(3): 1472 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, I. Gal, C. Vermes, M.-L. Alegre, A. S. F. Chong, L. Chen, Q. Shao, V. Adarichev, X. Xu, T. Koreny, et al. Cutting Edge: Cbl-b: One of the Key Molecules Tuning CD28- and CTLA-4-Mediated T Cell Costimulation J. Immunol., December 15, 2004; 173(12): 7135 - 7139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Jones, D. Bourdette, N. Moes, A. Vandenbark, A. Zamora, and H. Offner Epitope Spreading Is Not Required for Relapses in Experimental Autoimmune Encephalomyelitis J. Immunol., February 15, 2003; 170(4): 1690 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Furtado, M. A. C. de Lafaille, N. Kutchukhidze, and J. J. Lafaille Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function J. Exp. Med., September 16, 2002; 196(6): 851 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, T. Bardos, D. Li, I. Gal, C. Vermes, J. Xu, K. Mikecz, A. Finnegan, S. Lipkowitz, and T. T. Glant Cutting Edge: Regulation of T Cell Activation Threshold by CD28 Costimulation Through Targeting Cbl-b for Ubiquitination J. Immunol., September 1, 2002; 169(5): 2236 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Ye, B. Press, S. Kissler, X.-F. Yang, L. Lu, C. H. Bassing, B. P. Sleckman, M. Jansson, V. Panoutsakopoulou, L. A. Trimble, et al. T Cell Costimulation through CD28 Depends on Induction of the Bcl-x{gamma} Isoform: Analysis of Bcl-x{gamma}-deficient Mice J. Exp. Med., July 1, 2002; 196(1): 87 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Williams, J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance J. Immunol., November 1, 2001; 167(9): 4987 - 4995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pechhold, N. B. Patterson, C. Blum, C. L. Fleischacker, B. O. Boehm, and D. M. Harlan Low Dose Streptozotocin-Induced Diabetes in Rat Insulin Promoter-mCD80-Transgenic Mice Is T Cell Autoantigen-Specific and CD28 Dependent J. Immunol., February 15, 2001; 166(4): 2531 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Winer, I. Astsaturov, R. K. Cheung, L. Gunaratnam, V. Kubiak, M. A. Cortez, M. Moscarello, P. W. O'Connor, C. McKerlie, D. J. Becker, et al. Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis J. Immunol., February 15, 2001; 166(4): 2831 - 2841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Silver, K. S. Hathcock, C.-C. Chan, B. Wiggert, and R. R. Caspi Blockade of Costimulation Through B7/CD28 Inhibits Experimental Autoimmune Uveoretinitis, But Does Not Induce Long-Term Tolerance J. Immunol., November 1, 2000; 165(9): 5041 - 5047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Saegusa, N. Ishimaru, K. Yanagi, N. Haneji, M. Nishino, M. Azuma, I. Saito, and Y. Hayashi Autoantigen-Specific CD4+CD28low T Cell Subset Prevents Autoimmune Exocrinopathy in Murine Sjogren's Syndrome J. Immunol., August 15, 2000; 165(4): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Chang, B. M. Segal, and E. M. Shevach Role of Costimulation in the Induction of the IL-12/IL-12 Receptor Pathway and the Development of Autoimmunity J. Immunol., January 1, 2000; 164(1): 100 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-X. Gao, H. Zhang, X.-F. Bai, J. Wen, X. Zheng, J. Liu, P. Zheng, and Y. Liu Perinatal Blockade of B7-1 and B7-2 Inhibits Clonal Deletion of Highly Pathogenic Autoreactive T Cells J. Exp. Med., April 15, 2002; 195(8): 959 - 971. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
